毛细管电泳/非接触式电导法分离检测氧氟沙星对映体

采用毛细管电泳-电容耦合非接触式电导(CE-C4D),以20 mmol/L HAc + 6 mmol/L NaAc+12 mg/L羟丙基甲基纤维素(HPMC)+35 mmol/L羟丙基-β-环糊精(HP-β-CD)为电泳运行液,在熔融石英毛细管柱(45 cm×50 μm i.d.,有效长度 40 cm)中,正高压分离,手性药物氧氟沙星对映体获得良好的基线分离,线性检测范围为0.8～40 mg/L,检出限为0.3 mg/L.考察了电泳运行液组成、二元手性选择剂(HP-β-CD和HPMC)的浓度、进样方式和样品基质等对灵敏度和分离度的影响.本方法应用于市售外消旋和左旋氧氟沙星片剂中对映体的分离测定.     

毛细管电泳/非接触式电导法分离检测手性药物氨氯地平对映体

采用毛细管电泳/电容耦合非接触式电导( CE/C4 D),以18 mmol/L柠檬酸+6 mmol/L氨水+12 mg/L羟丙基甲基纤维素(HPMC)+ 35 mmol/L羟丙基-β-环糊精(HP-β-CD)为电泳运行液,熔融石英毛细管(50μm i.d.×45 cm,leff=40 cm),正高压(+15 kV)分离...     

氨氯地平对映体的高效毛细管电泳手性拆分

建立了氨氯地平对映体的高效毛细管电泳手性拆分方法。考察了背景电解质的PH值和浓度，手性选择剂浓度，有机改性剂种类及浓度对分离的影响，对分离条件进行了优化。结果表明，在含30mg/mL羟丙基-β-CD（HP－β-CD）和10％甲醇的40mmol/L Tris-H3PO4(pH2.5)体系中，对映体达到基线分离，分离度（Rs)为3．4。     

使用二元环糊精体系毛细管电泳法分离手性药物

采用高效毛细管区带电泳法，分别以羟丙基-β-环糊精（HP-β-CD）和高磺化-β-环糊精（HS-β-CD）及二者混合物为手性选择剂，研究了5种药物的对映体分离，并取得很好的对映体分离结果。比较了HP-β-CD和HS-β-CD手性识别能力，分析了二元环糊精体系的“协同效应”。     

高效毛细管电泳对克伦特罗对映体的分离及定量检测

以羟丙基-β-环糊精(HP-β-CD)作为手性添加剂,采用毛细管区带电泳(CZE)成功分离了克伦特罗(Clenbuterol,Cle)对映体.研究了β-CD种类与浓度,缓冲液pH值及浓度,操作温度等对分离的影响.结果表明,以30 mmol/L的HP-β-CD为手性添加剂,50 mmol/L的磷酸盐缓冲溶液(pH 2.5)为缓中液,分离电压24 kV,操作温度20℃,可使Cle对映体实现基线分离,其分离度为6.78.对拆分机理也进行了探讨,测定了HP-β-CD与两对映体的结合常数及热力学参数;对CZE定量能力(线性,精度)进行了考察,R和S型的线性相关系数都大于0.998,两者的相对标准偏差(RSD)均低于2.2%.     

毛细管电泳手性拆分美托洛尔、阿普洛尔和卡替洛尔对映体

提出了毛细管电泳手性拆分β-受体阻滞剂美托洛尔、阿普洛尔、卡替洛尔的方法。考察手性拆分剂的种类及浓度、缓冲溶液的浓度及pH对手性拆分的影响。在95mmol.L-1Tris-H3PO4缓冲溶液中添加15mmol.L-1羟丙基-β-环糊精(HP-β-CD)和5g.L-1羧甲基-β-环糊精(CM-β-CD),美托洛尔对映体和阿普洛尔对映体分别在pH3.2和pH3.8获得基线分离,卡替洛尔对映体在同一分离条件下在pH3.8获得较好分离,分离度达1.0。     

手性流动相HPLC法拆分萘普生对映体的研究

将β-环糊精、甲基-β-环糊精、羟丙基-β-环糊精、L-脯氨酸作为手性流动相添加剂,系统地研究了D,L-萘普生在RP-HPLC系统中的拆分.分别考察了手性流动相的种类,手性试剂羟丙基-β-环糊精的浓度,流动相的pH值,修饰剂的种类及浓度,三乙胺浓度和柱温等对拆分效果的影响,以HP-β-CD为手性流动相添加剂,建立了HP-β-CD手性流动相分离萘普生对映体的方法.结果表明：当流动相为25 mol/L HP-β-CD、体积分数15%乙醇、体积分数0.5%三乙胺、pH3.5、柱温t25℃、流速V=1 mL/min时萘普生对映体得到了良好的基线分离,分离因子α可达1.29.     

毛果芸香碱对映体的毛细管电泳手性分离

采用β-环糊精及其衍生物作为手性选择剂对毛果芸香碱对映体进行了分离,研究了环糊精类型和浓度对分离的影响,同时考察了背景电解质pH、操作电压和温度等因素对对映体分离的影响;结果表明,采用羟丙基-β-环糊精(HP-β-CD)可以使毛果芸香碱对映体达到基线分离,优化条件下手性分离度可达2．79,为此类药物提供了一种简便、快速的毛细管电泳手性分离分析方法。     

固相萃取-毛细管电泳法测定免血清中的山茛菪碱对映体

建立一种可用于定量的毛细管电泳法分离山莨菪碱对映体.系统研究了三种手性选择剂:羟丙基-β-环糊精(HP-β-CD),甲基-β-环糊精(Me-β-CD),羧甲基-β-环糊精(CM-β-CD)及其浓度、缓冲溶液浓度和pH对山莨菪碱拆分的影响.在110 mmol/L Tris-H3PO4缓冲液中加入20.0 mg/mL HP-β-CD和5.0 mg/mL CM-β-CD(pH 4.0)条件下,山莨菪碱的4个对映体达到基线分离.血清样品通过崮相萃取预处理和浓缩,对映体的固相萃取回收率在82.9%～90.7%,相对标准偏差RSD%均小于7%.山莨菪碱的4个对映体血标准溶液浓度与电泳峰面积在77.86～0.39μg/mL范围内呈良好的线,r≥0.999,检出限(S/N=3)为0.08 μg/mL.平均日内和日间精密度(RSD%)分别小于4.2%和6.5%,方法回收率为95.1%和105%.建立的方法准确、可靠,应用于监测兔连续3 d口服75 mg山莨菪碱后血清中山莨菪碱的血药浓度,结果满意.     

固相萃取-毛细管电泳法测定兔血清中的山莨菪碱对映体

建立一种可用于定量的毛细管电泳法分离山莨菪碱对映体. 系统研究了三种手性选择剂: 羟丙基-β-环糊精 (HP-β-CD), 甲基-β-环糊精 (Me-β-CD), 羧甲基-β-环糊精(CM-β-CD) 及其浓度、缓冲溶液浓度和 pH 对山莨菪碱拆分的影响. 在110 mmol/L Tris-H3PO4缓冲液中加入20.0 mg/mL HP-β-CD和5.0 mg/mL CM-β-CD (pH 4.0)条件下, 山莨菪碱的4个对映体达到基线分离. 血清样品通过固相萃取预处理和浓缩, 对映体的固相萃取回收率在82.9%～90.7%, 相对标准偏差RSD%均小于7 %. 山莨菪碱的4个对映体血标准溶液浓度与电泳峰面积在77.86～0.39 μg/mL范围内呈良好的线性, r≥0.999, 检出限(S/N＝3)为0.08 μg/mL. 平均日间和日内精密度(RSD% )分别小于6.1% 和4.8%, 方法回收率为97.4% 和105.4%. 建立的方法准确、可靠, 应用于监测兔连续3 d口服75 mg 山莨菪碱后血清中山莨菪碱的血药浓度, 结果满意.     

酸催化的二芳基甲醇脱水环化氧化芳构化直接构筑4-芳基喹啉

我们发展了酸催化的二芳基甲醇的脱水环化氧化芳构化的方法,直接高产率（高达81%）的合成轴手性的4-芳基喹啉.而且,Lewis酸Zn（OTf）₂和手性膦酸都能催化这个反应,初步的不对称研究可以用er 71：29得到产物.     

双手性选择单元手性固定相的研究进展

手性固定相（chiral stationary phase,CSP）作为手性色谱分离的核心技术,在手性化合物的识别和分离中得到广泛应用。以双手性选择单元结合作为CSP是近些年的研究热点,研究表明,两种手性选择单元相结合的CSP可增加手性识别位点,显著提高分离效果。本文介绍了近几年双手性选择单元手性固定相在手性分离中的研究进展,并对其发展前景进行了展望。     

16种手性化合物在不同自制手性固定相上的拆分比较

采用高效液相色谱法,在自制的纤维素-三(3,5-二甲基苯基氨基甲酸酯)(ATEO-OD)、纤维素-三(4-甲基苯基氨基甲酸酯)(ATEO-OG)和纤维素-三(4-甲基苯基甲酸酯)(ATEO-OJ)3种手性柱上对16种不同结构的手性化合物进行了拆分和比较.试验结果表明:16个手性样品在这3种手性固定相上分别获得了不同程度的拆分,A TEO-OD对所分析样品具有更好的手性识别能力,ATEO-OG和ATEO-OJ的手性识别能力相当.     

Simultaneous chiral analyses of multiple analytes: case studies, implications and method development considerations

The field of chiral separations had a modest beginning some two decades ago. However, due to rapid technological advancement coupled with simultaneous availability of innovative chiral stationary phases and novel chiral derivatization agents, the field of chiral separations has now totally outpaced many other separation fields. Keeping pace with rapid changes in the field of chiral separations, investigators continue to add stereoselective pharmacokinetic, pharmacodynamic, pharmacologic and toxicological data of new and/or marketed racemic compounds to the literature. Examination of the evolution of chiral separations suggests that in the beginning many investigators attempted to separate and quantify a single pair of enantiomers, adopting either direct (separation made on a chiral stationary phase) or indirect (separation made following precolumn conversion of enantiomers to corresponding diastereomers) approaches. However, more recent trends in chiral separations suggest that investigators are attempting to separate and quantify multiple pairs of enantiomers with available technologies. Added to this, some interesting trends have been observed in many of the recently reported chiral applications, including preferences regarding internal standard selection, mobile phase contents and composition, sorting out issues with mass spectrometric detection, determination of elution order, analytical manipulations of metabolite(s) without reference standards and addressing some specificity-related issues. This review mainly focuses on chiral separations involving multiple chiral analytes and attempts to justify the need for such chiral separations involving multiple analytes. In this context, several cases studies are described on the utility and applicability of such chiral separations under discrete headings to provide an account to the readership on the implications of such tasks. The topics of case studies covered in this review include: (a) therapy markers--differentiation from drug abuse and/or applicability in forensics; (b) role in pharmacogenetic/polymorphic evaluation; (c) monitoring and understanding the role of parent and active metabolite(s) in clinical and preclinical investigations; (d) exploration on the pharmacokinetic utility of an active chiral metabolite vis-a-vis the racemic parent moiety; (e) understanding the chirality play in delineating peculiar toxic effects; (f) exploration of chiral inversion phenomenon, and understanding the role of stereoselective metabolism. For the further benefit of readership, some select examples (n = 19) of the separation of multiple chiral analytes with appropriate information on chromatography, detection system, validation parameters and applicable conclusion are also provided. Finally, the review covers some useful considerations for method development involving multiple chiral analytes.     

Last ten years (2008–2018) of chiral ligand‐exchange chromatography in HPLC: An updated review

Chiral ligand‐exchange chromatography is one of the elective strategies for the direct enantioresolution of small chelating compounds: amino acids, diamines, amino alcohols, diols, small peptides, etc. Unlike other methods, the interaction between chiral selector and analyte enantiomers is mediated by a cation, thus producing diastereomeric ternary complexes. Two main approaches are conventionally applied in chiral ligand‐exchange chromatography. The first relies upon chiral stationary phases where the chiral selector is either covalently immobilized or physically adsorbed onto suitable packing materials (coated phases). In the second approach, chiral molecules are added to the eluent, thus generating chiral eluent systems. Among the advantages of chiral ligand‐exchange chromatography, the generation of UV/vis‐active metal complexes, and the use of commercially available or easy‐to‐synthesize chiral selectors, in combination to rather inexpensive achiral columns for coated phases and chiral eluents, are noteworthy. Besides amino acids and amino alcohols, other species have proven suitable for chiral ligand‐exchange chromatography applications. Recently, the use of either chiral ionic liquids or micellar liquid chromatography systems as well as the successful off‐column formation of diastereomeric complexes have expanded the selectivity profiles and application fields. All of these issues are touched in the review, shedding light to the contributions appeared in the last decade.     

环境中手性污染物对映体分析方法的研究进展

手性污染物对映体尽管具有相似的物理化学性质,但在环境中的吸附、转移、降解等过程往往存在一定差异。生态安全问题与人类健康密切相关,因此,对手性环境污染物进行对映体水平上的分离分析是十分重要的研究课题。目前,国内外对环境中的手性污染物已开展了相关研究,然而全面评述相关分析测定方法的新进展鲜有报道。本文主要对环境中手性污染物的种类以及近5年环境中手性污染物的分析检测技术如液相色谱-质谱联用法、气相色谱-质谱联用法、毛细管电泳法、超临界流体色谱-质谱联用法等进行了归纳、综述和展望,为后续手性污染物的分析检测提供依据和参考。     

手性2-(口恶)唑烷酮的无溶剂合成法

在无溶剂条件下,手性的β-氨基醇和脲在160-180℃反应0．5-1 h,在200℃反应0．5 h,高产率地获得手性噁唑烷酮。     

手性2-噁唑烷酮的无溶剂合成法

手性2-噁唑烷酮的无溶剂合成法;手性氨基醇;脲;手性噁唑烷酮     

Methods of studies on quantitative structure–activity relationships for chiral compounds

Chiral compounds are very important in drug development, organic synthesis, materials science, toxicology, or environmental chemistry. Therefore, for creating new drugs, several methods have been suggested in recent years. In several laboratories in the world, some new methods for the derivations of the parameters were constructed and used for studies on quantitative structure–activity/property relationships of chiral molecules. The algorithms reviewed in this paper involve Zargeb group chiral indices, chiral molecular connectivity index, chiral topological charge index, chiral A_m index, chiral indices based on the matrixes, chiral indices based on chiral product, conformation‐independent chirality code, conformation‐dependent chirality code, quantitative two‐dimensional chirality degrees of benzenoids, and so on. Copyright © 2012 John Wiley & Sons, Ltd.